Assessment of Anxiety Disorders

Assessment of Anxiety Disorders Assessment of anxiety disorders should be systematic and clinically oriented, with the aim of understanding not only the diagnostic category but also severity, functional impact, comorbidity, and maintaining factors. A good assessment forms the foundation for treatment planning and follow-up. It should combine careful clinical interviewing with selective use of standardized tools. The assessment begins with a clear understanding of the presenting complaints. Patients may report excessive fear, worry, restlessness, autonomic symptoms, or avoidance, often presenting with somatic complaints. It is important to explore the onset, duration, course, and triggering factors, and whether symptoms are episodic or persistent. Early clarification helps differentiate between conditions such as panic disorder, where symptoms are sudden and episodic, and generalized anxiety disorder, where worry is chronic and pervasive. A structured symptom review using DSM-5-TR criteria helps identify the specific anxiety disorder. Each disorder has a distinct core fear and pattern of avoidance. For example, social anxiety disorder is characterized by fear of negative evaluation, while specific phobias involve circumscribed fears. Attention should be paid to frequency, intensity, and especially avoidance behaviors, as avoidance often predicts disability better than symptom severity alone. Assessing severity and functional impairment is essential. Anxiety disorders are clinically significant when they interfere with academic, occupational, social, or family functioning. Simple functional questions about activities the patient has stopped doing or is struggling to manage are often more informative than symptom counts. Quality of life and subjective distress should also be documented. Medical and substance-related causes must be reasonably excluded. Conditions such as thyroid dysfunction, anemia, cardiac illness, and respiratory disorders can mimic or exacerbate anxiety. Substance use, particularly caffeine, nicotine, alcohol, and cannabis, as well as certain medications like bronchodilators or steroids, should be reviewed. Investigations should be guided by clinical suspicion rather than performed routinely. Comorbidity is the rule rather than the exception in anxiety disorders. Depression commonly coexists and significantly influences prognosis and suicide risk. Other important comorbidities include substance use disorders, obsessive-compulsive disorder, trauma-related disorders, and personality traits such as avoidant or obsessive-compulsive traits. In students and young adults, sleep deprivation, burnout, and academic stress should be specifically assessed. Risk assessment is a necessary component, even though anxiety disorders are not classically associated with high suicide risk. Suicidal ideation, maladaptive coping strategies such as alcohol or benzodiazepine misuse, and severe avoidance leading to functional collapse should be explored, particularly when depressive symptoms are present. Standardized rating scales can be used as adjuncts to clinical assessment. Tools such as the GAD-7, Hamilton Anxiety Rating Scale, Panic Disorder Severity Scale, and Liebowitz Social Anxiety Scale are useful for quantifying severity and monitoring treatment response over time. They should support, not replace, clinical judgment. A comprehensive assessment should culminate in a psychological formulation. This includes identifying predisposing factors such as temperament and early experiences, precipitating stressors, perpetuating factors like avoidance and cognitive distortions, and protective factors including social support and coping skills. This formulation directly informs psychotherapeutic interventions, especially cognitive behavioral therapy. Finally, cultural and contextual factors should always be considered. In the Indian context, anxiety often presents with prominent somatic symptoms, stigma influences help-seeking, and family responses play a significant role in the course of illness. Understanding the patient’s explanatory model and treatment expectations improves engagement and outcomes.